| 
 | 
WH-4-023
Chemical Information
    
        
            M.Wt
            568.67
            Storage
            Please store the product under the reco...
More>> 
 | 
 
 
             | 
          
| 
 | 
PP1
Chemical Information
    
        
            M.Wt
            281.36
            Storage
            Please store the product under the reco...
More>> 
 | 
 
 
             | 
          
| 
 | 
PP2
Chemical Information
    
        
            M.Wt
            301.77
            Storage
            Please store the product under the reco...
More>> 
 | 
 
 
             | 
          
| 
 | 
Imatinib
Description of:Imatinib 
Imatinib (originally STI571) is a drug used to treat certain cancers. It is marketed by Novartis as Gleevec (USA) or Gl...
More>> 
 | 
 
 
             | 
          
| 
 | 
Dasatinib
Theoretical analysis:Dasatinib 
Molecular Formula: C22H28ClN7O3S  
Formula Weight: 506.02082  
CAS No.: 863127-77-9  
A...
More>> 
 | 
 
 
             | 
          
| 
 | 
Bafetinib(INNO-406)
Description of:Bafetinib(INNO-406) 
Bafetinib (INNO-406) is an orally available, dual Abl/Lyn kinase inhibitor that is up to 55-times more poten...
More>> 
 | 
 
 
             | 
          
| 
 | 
PCI-32765
Description of:PCI-32765 
PCI-32765 is highly active and well tolerated in CLL/SLL pts irrespective of high risk genomic abnormalities. Although...
More>> 
 | 
 
 
             | 
          
| 
 | 
Bafetinib
Description of:Bafetinib 
Bafetinib (INNO-406) is an orally available, dual Abl/Lyn kinase inhibitor (cell IC50 : 11 ~ 22 nM). 
Theoreti...
More>> 
 | 
 
 
             | 
          
| 
 | 
Fingolimod(FTY720)
Description of:Fingolimod(FTY720) 
Fingolimod is Src-bcr-Abl Inhibitor & S1P receptor agonist with IC50 of 0.137, 10.98 nM for (S)- and (R)-...
More>> 
 | 
 
 
             | 
          
| 
 | 
Saracatinib
Description of:Saracatinib 
AZD0530 inhibited tumor growth in a manner independent of dose and inhibited phosphorylation of Focal adhesion kinas...
More>> 
 | 
 
 
             |